View Top Employees for Adrestia Therapeutics
|
Website | adrestia.com |
|
Industry | Biotechnology |
|
Location | Cambridge, Cambridgeshire, United Kingdom |
|
Employees | 9 |
|
Founded | 2018 |
|
HQ | Moneta Building 280 Babraham Research Campus |
|
Funding | 232,569,774 USD |
|
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
|
|
Website | adrestia.com |
|
|
Industry | Biotechnology |
|
|
Location | Cambridge, Cambridgeshire, United Kingdom |
|
|
Employees | 9 |
|
|
Founded | 2018 |
|
linkedin.com/company/adrestia-therapeutics | |
|
|
HQ | Moneta Building 280 Babraham Research Campus |
|
|
Funding | 232,569,774 USD |
Top Competitors for Adrestia Therapeutics
Adrestia Therapeutics Questions
Where are Adrestia Therapeutics's headquarters?
Adrestia Therapeutics's headquarters are in Moneta Building 280 Babraham Research Campus
What is Adrestia Therapeutics's official website?
Adrestia Therapeutics's website is adrestia.com
How many employees are working in Adrestia Therapeutics right now?
Adrestia Therapeutics has
9 employees.
View the Email and Phone Numbers for all 9 working at Adrestia Therapeutics.
What is Adrestia Therapeutics's industry?
Adrestia Therapeutics's industry is
Biotechnology
Who are Adrestia Therapeutics's top competitors?
Adrestia Therapeutics's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What are Adrestia Therapeutics's categories?
Adrestia Therapeutics's categories are -
What is Adrestia Therapeutics's location?
Adrestia Therapeutics's location is
Cambridge, Cambridgeshire, United Kingdom
When was Adrestia Therapeutics's founded?
Adrestia Therapeutics's founding year is 2018
What is Adrestia Therapeutics's funding?
Adrestia Therapeutics's funding is 232,569,774 USD
What is Adrestia Therapeutics's current status?
Adrestia Therapeutics's current status is operating
Top Adrestia Therapeutics Employees
Advisor
bunting@abingworth.com
+1650-926-0600
Co Founder
balmusg@gmail.com
+44755-444-7275
Research Scientist
Senior Scientist
Advisor
bunting@abingworth.com
+1650-926-0600
Founder, Chief Scientific Officer And Interim Chief Executive Officer
Research Technician
